NYSE:TPVG - TriplePoint Venture Growth BDC Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $10.96
  • Forecasted Upside: -25.10 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$14.63
▲ +0.11 (0.76%)
1 month | 3 months | 12 months
Get New TriplePoint Venture Growth BDC Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TPVG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TPVG

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$10.96
▼ -25.10% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for TriplePoint Venture Growth BDC in the last 3 months. The average price target is $10.96, with a high forecast of $13.00 and a low forecast of $8.50. The average price target represents a -25.10% upside from the last price of $14.63.
Buy
The current consensus among 6 contributing investment analysts is to buy stock in TriplePoint Venture Growth BDC. This rating has held steady since June 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/10/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/9/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/8/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/3/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/1/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/3/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/19/2020JMP SecuritiesInitiated CoverageOutperform$13.00Medium
i
8/6/2020Wells Fargo & CompanyBoost Price TargetOverweight$11.25 ➝ $11.75Low
i
8/6/2020LADENBURG THALM/SH SHBoost Price TargetBuy$9.00 ➝ $12.00Medium
i
5/13/2020Compass PointDowngradeBuy ➝ Neutral$8.00 ➝ $8.50High
i
Rating by Casey Alexander at Compass Point
5/8/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$15.50 ➝ $11.50High
i
5/7/2020Keefe, Bruyette & WoodsBoost Price TargetMarket Perform$8.00 ➝ $9.00Low
i
4/27/2020Wells Fargo & CompanyBoost Price TargetOverweight$9.00 ➝ $9.25High
i
4/2/2020Compass PointUpgradeNeutral ➝ Buy$8.00Low
i
3/25/2020Wells Fargo & CompanyLower Price TargetOverweight$13.75 ➝ $9.00Low
i
3/5/2020Wells Fargo & CompanyLower Price TargetOverweight$14.50 ➝ $13.75Medium
i
3/5/2020LADENBURG THALM/SH SHUpgradeNeutral ➝ Buy$13.50Medium
i
1/14/2020JMP SecuritiesInitiated CoverageOutperform$15.50Low
i
9/19/2019Wells Fargo & CompanyBoost Price TargetOutperform$15.00 ➝ $16.00Low
i
7/8/2019Nomura SecuritiesInitiated CoverageBuy ➝ Buy$16.00Medium
i
5/6/2019Compass PointDowngradeBuy ➝ Neutral$14.50Low
i
9/20/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$14.25Medium
i
8/13/2018Compass PointSet Price TargetBuy$14.00Low
i
Rating by Casey Alexander at Compass Point
8/2/2018Compass PointSet Price TargetBuy$15.00Low
i
Rating by Casey Alexander at Compass Point
8/1/2018Keefe, Bruyette & WoodsSet Price TargetHold$14.00Low
i
Rating by Ryan Lynch at Keefe, Bruyette & Woods
4/16/2018Keefe, Bruyette & WoodsInitiated CoverageMarket PerformLow
i
12/12/2017LADENBURG THALM/SH SHInitiated CoverageNeutral ➝ NeutralLow
i
11/28/2017Compass PointUpgradeNeutral ➝ BuyHigh
i
8/29/2017Compass PointDowngradeBuy ➝ Neutral$14.41 ➝ $14.00High
i
9/22/2016Compass PointUpgradeNeutral ➝ Buy$12.30N/A
i
8/25/2016Compass PointDowngradeBuy ➝ Neutral$12.25N/A
i
6/29/2016Compass PointInitiated CoverageBuy$12.75N/A
i
6/22/2016Janney Montgomery ScottInitiated CoverageNeutral$13.00N/A
i
5/2/2016LADENBURG THALM/SH SHInitiated CoverageBuy$13.25N/A
i
(Data available from 3/3/2016 forward)
TriplePoint Venture Growth BDC logo
TriplePoint Venture Growth BDC Corp is a business development company specializing investments in growth stage. It also provides debt financing to venture growth space companies which includes growth capital loans, equipment financings, revolving loans, and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It does not take board seat in the company.
Read More

Today's Range

Now: $14.63
$14.56
$14.63

50 Day Range

MA: $13.96
$13.25
$14.73

52 Week Range

Now: $14.63
$2.80
$14.79

Volume

33 shs

Average Volume

187,593 shs

Market Capitalization

$451.01 million

P/E Ratio

11.99

Dividend Yield

10.02%

Beta

1.9

Frequently Asked Questions

What sell-side analysts currently cover shares of TriplePoint Venture Growth BDC?

The following Wall Street sell-side analysts have issued reports on TriplePoint Venture Growth BDC in the last twelve months: Compass Point, Deutsche Bank Aktiengesellschaft, JMP Securities, Keefe, Bruyette & Woods, LADENBURG THALM/SH SH, TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for TPVG.

What is the current price target for TriplePoint Venture Growth BDC?

6 Wall Street analysts have set twelve-month price targets for TriplePoint Venture Growth BDC in the last year. Their average twelve-month price target is $10.96, suggesting a possible downside of 24.5%. JMP Securities has the highest price target set, predicting TPVG will reach $13.00 in the next twelve months. Compass Point has the lowest price target set, forecasting a price of $8.50 for TriplePoint Venture Growth BDC in the next year.
View the latest price targets for TPVG.

What is the current consensus analyst rating for TriplePoint Venture Growth BDC?

TriplePoint Venture Growth BDC currently has 2 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TPVG will outperform the market and that investors should add to their positions of TriplePoint Venture Growth BDC.
View the latest ratings for TPVG.

What other companies compete with TriplePoint Venture Growth BDC?

How do I contact TriplePoint Venture Growth BDC's investor relations team?

TriplePoint Venture Growth BDC's physical mailing address is 2755 SAND HILL ROAD SUITE 150, MENLO PARK CA, 94025. The investment management company's listed phone number is 650-854-2090 and its investor relations email address is [email protected] The official website for TriplePoint Venture Growth BDC is www.tpvg.com.